Valuation Ipsen

Stocks

Real-time Euronext Paris 11:03:56 11/09/2026 +04			5-day change	1st Jan Change
156.30 ^EUR	-0.06%		-5.10%	+31.34%

09-08	Rubis posts gold-standard results, telecom operators talk, Novartis has to pull the parachute.
08-21	Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc.	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	6,621	8,279	8,912	9,155	9,770	12,823	-	-
Change	-	25.05%	7.65%	2.72%	6.72%	31.25%	-	-
Enterprise Value (EV) ¹	6,758	7,894	8,860	9,020	9,225	11,585	10,524	9,714
Change	-	16.81%	12.22%	1.81%	2.28%	25.58%	-9.16%	-7.7%
P/E	10.4x	12.9x	14x	26.7x	22.4x	13x	13.3x	13.4x
PBR	2.42x	-	2.36x	2.22x	2.3x	2.51x	2.13x	1.84x
PEG	-	20.02x	-13.67x	-0.6x	0.8x	0x	-5.97x	-22.26x
Capitalization / Revenue	2.31x	2.74x	2.85x	2.69x	2.49x	2.82x	2.77x	2.65x
EV / Revenue	2.36x	2.61x	2.83x	2.65x	2.35x	2.55x	2.27x	2.01x
EV / EBITDA	5.8x	5.86x	10.1x	7.52x	6.67x	6.12x	5.93x	5.42x
EV / EBIT	6.68x	7.08x	8.85x	8.13x	7.13x	7x	6.98x	6.5x
EV / FCF	8.31x	9.02x	12.5x	11.6x	8.93x	8.98x	8.65x	7.9x
FCF Yield	12%	11.1%	8.02%	8.59%	11.2%	11.1%	11.6%	12.7%
Dividend per Share ²	1.2	1.2	1.2	1.4	1.4	1.535	1.532	1.655
Rate of return	1.49%	1.19%	1.11%	1.26%	1.18%	0.98%	0.98%	1.06%
EPS ²	7.76	7.81	7.73	4.15	5.32	12.02	11.75	11.68
Distribution rate	15.5%	15.4%	15.5%	33.7%	26.3%	12.8%	13%	14.2%
Net sales ¹	2,869	3,025	3,128	3,401	3,929	4,543	4,637	4,840
EBITDA ¹	1,166	1,348	881.4	1,200	1,383	1,893	1,776	1,792
EBIT ¹	1,011	1,115	1,001	1,109	1,294	1,656	1,508	1,494
Net income ¹	646.6	647.5	647.2	347.3	444.5	1,011	985.4	981.3
Net Debt ¹	137.8	-384.7	-52.9	-134.9	-544.5	-1,238	-2,299	-3,109
Reference price ²	80.50	100.50	107.90	110.70	119.00	156.40	156.40	156.40
Nbr of stocks (in thousands)	82,243	82,380	82,599	82,700	82,100	81,990	-	-
Announcement Date	11/02/22	09/02/23	08/02/24	13/02/25	12/02/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPSEN	13.01x	2.55x	6.12x	0.98%	14.91B
ELI LILLY AND COMPANY	31.96x	11.62x	23.56x	0.62%	1,001B
JOHNSON & JOHNSON	29.63x	-	-	2.02%	642B
ABBVIE INC.	32.65x	7.56x	15.72x	2.69%	451B
ROCHE HOLDING AG	18.78x	4.58x	11.35x	2.9%	340B
NOVARTIS AG	19.52x	5.11x	12.66x	3.19%	263B
ASTRAZENECA PLC	20.44x	4.2x	12.01x	2.1%	247B
AMGEN INC.	24.19x	6.38x	11.35x	2.64%	207B
NOVO NORDISK A/S	12.74x	4.63x	9.67x	3.94%	197B
GILEAD SCIENCES, INC.	-43.8x	6.4x	24.98x	2.27%	180B
Average	15.91x	5.89x	14.16x	2.33%	354.12B
Weighted average by Cap.	23.19x	7.72x	17.12x	2.04%